Search

everythinglearnresearchcommunity

for

Search:↓

Two transplant patients on cyclosporine unexpectedly developed hair loss.

Alopecia Areata is an autoimmune disease affecting hair follicles, influenced by genetic and environmental factors, with rodent models being essential for research.

Leflunomide successfully treated a rare skin condition in a liver transplant patient.

The decision board effectively helps lupus nephritis patients in Brazil choose treatments by clearly presenting options and side effects.

Early diagnosis and aggressive treatment are key for managing rare scalp disorders that cause permanent hair loss.

Some anticonvulsant drugs can cause skin reactions, ranging from mild to severe, and managing these reactions is important for patient care.

Patients with chronic graft-versus-host disease often have skin problems like vitiligo and alopecia areata.

Effective wound healing after HS treatments can be achieved with various methods like moist dressings and skin grafting.

Certain daily habits like stress, diet, and sleep can affect the severity of hair loss in alopecia areata.

Sex hormones may affect COVID-19 severity, with estrogen possibly reducing risk and testosterone potentially increasing it.

Inflammation around hair follicles may worsen hair loss; evaluating and treating it can improve transplant results.

Androgen deprivation therapy might be better for preventing COVID-19 than treating it.

Antiviral medication valganciclovir may improve skin and hair in Trichodysplasia Spinulosa patients.

Early and aggressive treatment with individualized care plans is crucial for managing pediatric systemic lupus erythematosus.

Some patients developed hair loss after islet cell transplant possibly due to their immune-suppressing medications.

The virus linked to a rare disease was found in a patient's blood and urine before skin symptoms appeared.

Certain liver diseases respond well to specific treatments and have varying risks for liver cancer.

Corticosteroids are the most effective treatment for Satoyoshi syndrome.

A 70-year-old woman with bronchiectasis developed a rare immune disease due to a bacterial infection, requiring a difficult balance of treatments.

Oral tacrolimus helped a rheumatoid arthritis patient regrow hair lost due to alopecia areata.

A five-month-old boy with Omenn syndrome successfully recovered after a stem cell transplant with reduced intensity conditioning.

A boy with a rare skin condition and kidney disease improved with cyclosporine after steroids failed, suggesting a new treatment approach.

Newly found stem cells in horse hooves show promise for treating a hoof disease called laminitis.

Rituximab may be an effective treatment for Cronkhite-Canada syndrome with kidney disease.

Steroids can treat skin conditions but must be used carefully to avoid side effects.

Dupilumab improved severe atopic dermatitis in a patient who didn't respond to other treatments.

There is no gold standard treatment for hidradenitis suppurativa due to insufficient evidence.

The document concludes that various skin conditions have specific treatments, ranging from antihistamines for urticaria to surgery and medication for tumors and chronic skin diseases.

Restoring immune privilege in hair follicles could help treat certain types of hair loss.

Different types of atopic dermatitis were linked to specific genetic and immune changes, suggesting that severe cases might need stronger immune-targeting treatments.